| Revenue growth | 30% YoY Consolidated |
|---|---|
| Margins | Consolidated EBITDA margins improved significantly; chemical margins reached 9.3% |
| Demand visibility | Increasing industrial activity and growing demand from customer segments |
| Management confidence | High; citing Vision 2030 and favorable business prospects |
Growth
FY26 Consolidated Revenue reached INR 981 Cr (+30% YoY). EBITDA grew 90% to INR 93.8 Cr.
Outlook
Commissioning Triacetin and Penta derivatives projects shortly. Vision 2030 aims for sustainable growth; Promoters infusing INR 49.5 Cr.
Risks
Exposed to geopolitical tensions, high tariffs, and currency volatility/inflation specifically in Ethiopian operations (KAT).
Investor Presentation filed with NSE, NSE: KANORICHEM. Summary written with AI assistance from the document.
Kanoria Chemicals & Industries Ltd: key numbers
- Share price
- ₹198.55
- Market cap
- ₹867.5 Cr
- Revenue (annual)
- ₹981.4 Cr
- Net profit (annual)
- ₹120.8 Cr
- P/E (TTM)
- 5.6×Sector 37.5×
- Promoter holding
- 74.40%+0.00% QoQ
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kanoria Chemicals & Industries Ltd
All →Kanoria Chemicals & Industries Annual General Meeting
Kanoria Chemicals & Industries Limited conducted its 66th Annual General Meeting on September 2, 2026, via video conferencing. The meeting covered routine ordinary and special business resolutions.
Kanoria Chemicals & Industries Q1 FY27 Results: Turns Profitable, Net Profit ₹26.4 Cr
Kanoria Chemicals & Industries Ltd reported revenue from operations of ₹460.4 Cr (+128.6% YoY) and net profit of ₹26.4 Cr for Q1 FY27.
- Key figure
- Net profit ₹26.4 Cr
Kanoria Chemicals & Industries Q4 FY26 Results: Turns Profitable, Net Profit ₹31.6 Cr
Kanoria Chemicals & Industries Ltd reported revenue from operations of ₹304.4 Cr (+42.3% YoY) and net profit of ₹31.6 Cr for Q4 FY26.
- Key figure
- Net profit ₹31.6 Cr